GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. - Wikidata - awgldk - TriplyDB

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

http://www.wikidata.org/entity/Q33927320

about

Diagnosing COPD: advances in training and practice - a systematic review COPD: the patient perspective A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease Chronic obstructive pulmonary disease: respiratory review of 2013 Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.New GOLD classification: longitudinal data on group assignment.Predicting frequent COPD exacerbations using primary care data Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.Implementation of GOLD consensus report in real life: results from the Velletri-Lariano (VELA) cohort.Comparison of Korean COPD guideline and GOLD initiative report in term of acute exacerbation: a validation study for Korean COPD guideline.The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study Chronic obstructive pulmonary disease: respiratory review of 2014.Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test.The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.Phenotype of normal spirometry in an aging population.External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort)Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics.Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study.Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial Phenotype of Spirometric Impairment in an Aging Population Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study.Fraction of exhaled nitric oxide measurements in the diagnoses of asthma in elderly patients.Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) a The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies.Chronic bronchitis is an independently associated factor for more symptom and high-risk groups.A year in the life of German patients with COPD: the DACCORD observational study Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies

P2860

Q26751313-C7AC9109-C4E9-400D-B29B-D5C1D724C7DA Q26764894-3862CCA9-201A-484E-8D67-6B583131A74C Q26801661-AD3ABD02-8A57-4958-BCB1-9BFA6CD1AD67 Q26864703-FE4624BD-1277-4DCC-921F-385808CF8B74 Q28070274-40FB347B-D421-4E55-9A42-F1C1875F04DA Q29416987-39C2EEE1-8C44-4198-A6E5-A4526FBDB901 Q30732307-7280E478-57DF-4719-8C2F-96079488F3AD Q31028327-B45861D2-504F-4A37-BCCD-7DFEE598D97A Q33705840-DC7199E3-4DCF-4064-AE92-DA277DCE0FA1 Q33718748-AE970D43-F94D-422F-93C6-DB1178A2D0D1 Q33910793-AE0C712B-366C-4E17-B15F-5AB3BCA05F2C Q34029980-40CD907F-0137-496C-B0AA-9AC4FB728946 Q34339200-8674BBD6-1872-45C9-85CE-FFF282B4A318 Q34440060-E58B40FF-3CA0-462A-BA0D-453908132EB2 Q34469716-93CCB967-BEED-4D78-9643-8F4F8CFA7C83 Q34550471-27C9124F-8081-4D94-9068-B04F4A5F3BD0 Q34754220-EE8A7B8B-E8E1-4CFE-9585-F1E5E840D2B8 Q35019225-2C2BD569-34C0-4496-AEA6-D712315BEFEE Q35541219-45522BF2-2215-4BC7-BFA1-4030A4001DB3 Q35565089-F299B0C8-970F-45D9-A757-7361908C2925 Q35915157-89552200-A316-44F6-860C-80F350E4956D Q35937943-0D24F507-ADA4-4154-BF86-499CE8C2E957 Q35970613-E3FF9907-933D-4B60-B161-1CF8735C4D32 Q35981939-7BDEFC0E-5A73-4436-8433-62B641BF8B97 Q36052363-14D219B6-C22C-4B82-9D6B-557B54B967F9 Q36081221-793C6EAF-8BF2-4242-8F1C-D85B8D8130EA Q36185922-46B7E747-DE47-4BC3-8347-2802601418FC Q36190129-67FD5DBE-C5E0-40BB-87F0-1097FF91E212 Q36207526-A585584F-DD18-48C4-8777-41A6B6E329BC Q36250075-E8BF757E-0EE6-4554-BD03-AA847F0BD1F2 Q36303220-67633D5C-B2CC-4B14-AD06-5C75DF45F2DA Q36535142-29F59968-0F1D-4D5C-9206-FE66078DC929 Q36778591-19E278E2-D9A6-4629-AAAE-5B2C6A4C9EFA Q36858183-89E017EA-BDBC-41B6-A63D-A794D354F3EB Q36907967-D8662A09-3039-429B-A90C-1B40FDA9C598 Q36926496-61BCEBB2-35AC-4BC6-BD67-FB41B675A7AA Q36929677-F0E3764A-C16E-4837-9773-E8DACC196B04 Q37042496-C2AB93C5-362F-4C2D-913D-E198E2E4AD4B Q37123265-E3646B26-4610-4BC6-99E7-145F6EA3FFC8 Q37494942-AD5E4EBE-5160-434E-A685-E6960F3579B8

P2860

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

http://www.wikidata.org/entity/Q33927320

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

@ast

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

@en

type

label

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

@ast

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

@en

prefLabel

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

@ast

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

@en

P1433

Q33927320-0A491585-421F-4380-8A96-8D132B1644DB

P1476

Q33927320-36902C2F-04B7-43D7-827E-405BE336FD2B

P2093

Q33927320-2B7B4376-4E5E-4868-B06B-CDF5500C4DBF

Q33927320-3A8B59A5-CEA3-41F4-8D84-FC985D520074

Q33927320-503B93C8-0C48-451B-93A2-7F301AAE20D4

Q33927320-7076FA05-442A-4D89-86DA-807E442A1BB9

Q33927320-79970085-D749-42C0-9004-BD832C4C2A3E

Q33927320-91812279-F03E-4544-A921-6978ABF5F45D

Q33927320-98C5050C-7B96-4FF4-84FF-C75748470246

Q33927320-9A90EA71-C19A-4520-AA1D-E7C84227C44A

Q33927320-AEE5C25E-F483-4EC7-B20D-3FFDADF2362F

Q33927320-B10F876E-2D12-4A86-9681-7564F00FFAE1

P2860

Q33927320-0B6748D2-6FB4-48E3-B48E-EF0C46A1521F

Q33927320-0DA338D9-F25E-4A48-A60F-B6223FE18AF7

Q33927320-143AB448-C2ED-4EAD-AB05-685DCFBF0A88

Q33927320-51A6FDD6-BF5E-4599-BB84-5717244D648D

Q33927320-69DC2603-A64C-4620-89F8-A818DDB9578F

Q33927320-75395AD9-0065-40DD-8411-9A288DABE1F2

Q33927320-81B0C70F-D775-453F-A465-09D05B4DDB2F

Q33927320-861FCCDF-6ED7-41BF-967A-038A68ADEE00

Q33927320-8718A982-7596-4E20-908D-2E1BD9DA211D

Q33927320-8747D85A-856F-4EB6-A25E-956EDE3D1166

P304

Q33927320-8420B1C1-533C-42C7-9925-E5943D9FF14C

P31

Q33927320-BC0EFDB6-ED80-4F15-BD01-21AE88DAC3C2

P356

Q33927320-0006AFAF-1EEA-4F60-9238-DBA86563B015

P433

Q33927320-BC4649FE-7ABE-4F9D-B12D-A08B97B1960C

P478

Q33927320-03A5D86D-BAEB-4073-BA61-C84B113E2D8C

P50

Q33927320-FA0242BE-BFFA-4261-8406-F4699ADB5A9C

P577

Q33927320-F709BF8D-F2CB-4DE7-B381-3E083BB74928

P5875

Q33927320-10EE0512-AFF4-4915-8D5B-2CF5EA98858B

P698

Q33927320-2224516E-6B7C-4423-A292-1E1A01E3E9B0

P932

Q33927320-B4FDBB42-DEFC-4035-98CD-69D0933EDFAF

P356

S2213-2600(12)70044-9

P1433

The Lancet. Respiratory medicine

P1476

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

@en

P2093

Barry J Make

http://www.w3.org/2001/XMLSchema#string

David A Lynch

http://www.w3.org/2001/XMLSchema#string

Douglas Curran-Everett

http://www.w3.org/2001/XMLSchema#string

Edwin K Silverman

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Regan

http://www.w3.org/2001/XMLSchema#string

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

George R Washko

http://www.w3.org/2001/XMLSchema#string

Hana Muellerova

http://www.w3.org/2001/XMLSchema#string

James D Crapo

http://www.w3.org/2001/XMLSchema#string

John E Hokanson

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Standardization of Spirometry, 1994 Update. American Thoracic Society

Epidemiology Standardization Project (American Thoracic Society)

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores

Genetic epidemiology of COPD (COPDGene) study design

Characterisation of COPD heterogeneity in the ECLIPSE cohort

Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation.

Patient-reported dyspnea in COPD reliability and association with stage of disease

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

P304

43-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S2213-2600(12)70044-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Anzueto

P577

2012-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259252324

http://www.w3.org/2001/XMLSchema#string

P698

24321803

http://www.w3.org/2001/XMLSchema#string

P932

4105297

http://www.w3.org/2001/XMLSchema#string